Trastuzumab Withdrawn Phase 2 Trials for Neoplasms, Lung / Lung Cancers / Breast Cancer / Neoplasms, Breast Diagnostic

IndicationsStatusPurposePhase
WithdrawnDiagnostic2
clinicaltrials.gov IdentifierTitleDrugs
NCT01679743GRN1005 for Brain Metastases From Breast or Lung Cancer